Danish SaleheenHuman loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinson's disease

Genome Aggregation Database Production Team, Genome Aggregation Database Consortium, 23andMe Research Team, Genome Aggregation Database Production Team, Genome Aggregation Database Consortium

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Danish SaleheenHuman loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinson's disease'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Earth & Environmental Sciences

Chemical Compounds